Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.831 USD | +5.04% | +11.02% | -90.07% |
May. 08 | Aptevo Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 11 | US Equity Markets Close Mixed After March Producer Price Inflation Data | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.23M |
---|---|---|---|---|---|
Net income 2024 * | -28M | Net income 2025 * | -28M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.09
x | P/E ratio 2025 * |
-0.1
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.9% |
1 day | +5.04% |
Managers | Title | Age | Since |
---|---|---|---|
Marvin White
CEO | Chief Executive Officer | 61 | 16-07-31 |
Daphne Taylor
DFI | Director of Finance/CFO | 57 | 16-04-30 |
Dirk Huebner
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Marvin White
CEO | Chief Executive Officer | 61 | 16-07-31 |
Director/Board Member | 69 | 16-07-31 | |
Director/Board Member | 80 | 16-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 0.85 | +7.45% | 100 155 |
24-06-07 | 0.7911 | -6.71% | 85,743 |
24-06-06 | 0.848 | +2.18% | 133,837 |
24-06-05 | 0.8299 | +4.92% | 144,511 |
24-06-04 | 0.791 | +0.38% | 230,461 |
Delayed Quote Nasdaq, June 10, 2024 at 12:34 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-90.07% | 3.23M | |
+18.23% | 125B | |
+13.49% | 108B | |
-7.33% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.51% | 16.37B | |
+1.13% | 13.58B | |
+27.75% | 11.66B |
- Stock Market
- Equities
- APVO Stock